Evidence map›Paper›PMID 29666828›Full record

ArticleAmerican journal of clinical and experimental urology2018

Ten unanswered questions in cancer: "If this is true, what does it imply"?

Sarah R Amend, Amber E de Groot, Gonzalo Torga, Haley D Axelrod, Diane K Reyes, Kenneth C Valkenburg, Stephanie A Glavaris, Kenneth J Pienta

Abstract readEditorial
PubMed Full text at PMC
In one paragraph

Article in American journal of clinical and experimental urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Using Organoids to Tap Mammary Gland Diversity for Novel Insight.Journal of mammary gland biology and neoplasia · 2024
    Review
  2. Polyploid giant cancer cells and cancer progression.Frontiers in cell and developmental biology · 2022
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah R AmendThe James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins School of MedicineBaltimore, MD 21287, USA.
Amber E de GrootThe James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins School of MedicineBaltimore, MD 21287, USA.
Gonzalo TorgaThe James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins School of MedicineBaltimore, MD 21287, USA.
Haley D AxelrodThe James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins School of MedicineBaltimore, MD 21287, USA.
Diane K ReyesThe James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins School of MedicineBaltimore, MD 21287, USA.
Kenneth C ValkenburgThe James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins School of MedicineBaltimore, MD 21287, USA.
Stephanie A GlavarisThe James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins School of MedicineBaltimore, MD 21287, USA.
Kenneth J PientaThe James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins School of MedicineBaltimore, MD 21287, USA.

Funding

Tumor microvesicle-mediated modulation of the bone microenvironmentP01CA093900 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KELLER, EVAN T · 2004 to 2024
$29.6M
TRANS_NETWORK PROJECTSU54CA143803 · NCI · PRINCETON UNIVERSITY · PI AUSTIN, ROBERT H. · 2009 to 2013
$14.2M
Training Program in Cellular and Molecular MedicineT32GM008752 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI RAO, RAJINI · 2000 to 2019
$11.7M
Mechanisms That Regulate Dormancy of Disseminated Tumor Cells in the Bone MarrowU54CA163124 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHIOZAWA, YUSUKE · 2011 to 2015
$3.0M
Reactive Stroma and Tumor Associated Macrophages in Prostate Cancer ProgressionU01CA143055 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PIENTA, KENNETH J., ROWLEY, DAVID R · 2010 to 2014
$2.7M
Targeting SDF1/CXCR4 signaling to mobilize and kill circulating and disseminated prostate tumor cellsF32CA206394 · NCI · JOHNS HOPKINS UNIVERSITY · PI VALKENBURG, KENNETH C · 2016 to 2017
$112k
NCI NIH HHS F32 CA206394NCI NIH HHS P01 CA093900NCI NIH HHS U01 CA143055NCI NIH HHS U54 CA143803NCI NIH HHS U54 CA163124NIGMS NIH HHS T32 GM008752
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID29666828
PMCPMC5902718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.